Podiatrists in Buffalo, MN Accepting Medicare

2 Podiatrists found. Showing 1 - 2

Dr. Michael Dean O'borsky, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Highway 25 N, Buffalo, MN 55313 Phone: 763-682-1313    Fax: 763-271-3807

Dr. Steven Robert Smith, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 Catlin St, Buffalo, MN 55313 Phone: 763-682-5225

News Archive

Elevated responsivity of reward regions in the brain increases risk for future substance use

Do people get caught in the cycle of overeating and drug addiction because their brain reward centers are over-active causing them to experience greater cravings for food or drugs? In a unique prospective study Oregon Research Institute senior scientist Eric Stice, Ph.D., and colleagues tested this theory, called the reward surfeit model.

40 Days for Life prays before Planned Parenthood abortion center, director quits

The director of the Planned Parenthood abortion center in Bryan/College Station, Texas has resigned her job. Abby Johnson had worked at the clinic for eight years, but departed from the facility following a profound change of heart about abortion. The Planned Parenthood clinic was the location of the first-ever 40 Days for Life campaign in the fall of 2004, and the prayer and fasting initiative has been held outside the doors of Johnson's former workplace five additional times since 40 Days for Life began its rapid spread to 282 cities across all 50 states and several other countries.

Human pluripotent stem cells rely heavily on glycolysis to drive their metabolic activities

Human pluripotent stem cells, which can develop into any cell type in the body, rely heavily on glycolysis, or sugar fermentation, to drive their metabolic activities.

Expensive hepatitis drug draws huge sales

The demand for Gilead Sciences' Sovaldi, which costs $1,000 a pill, indicates how hard it is for insurers to curb the use of life-saving medicines. Meanwhile Humana names a former Goldman Sachs executive as finance chief.

Rigontec raises €4.8 million in second closing of Series A financing round

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, today announces it has raised €4.8 million in a second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture capital investor.

Read more Medical News

› Verified 1 days ago